Top Small Cap Stocks To Invest In Right Now

tags:ACHN,PQ,FCEL,CNR,

Small cap proppant and fracking stock CARBO Ceramics Inc (NYSE: CRR) reported Q4 2017 earnings before the market opened on Thursday as the Company struggles to transform/diversify itself and emerge from the oil and gas industry downturn.

Q4 revenue increased�108% year-over-year and 20% sequentially to $60.3 million with the�increase primarily attributable to increases in oilfield ceramic technology products, industrial ceramics, oilfield sand and environmental product revenues. The net loss was $17.4 million versus $15.2 million.

Full year 2017 revenue grew 83% to $188.8 million as revenue generated from the Oil and Gas sector grew 84% and revenue generated from the Industrial sector grew 76%. The net loss was $253.1 million versus a net loss of $80.2 million. Cash and cash equivalents stood at $68.169 million on December 31st versus $91.680 million a year earlier.

Top Small Cap Stocks To Invest In Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:

• [By Keith Speights]

  Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints. MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday. Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday. Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday. Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday. Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday. Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec. Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading. Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session. LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported. Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire. HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

  Find out what's going

Top Small Cap Stocks To Invest In Right Now: Petroquest Energy Inc(PQ)

Advisors' Opinion:

• [By Ethan Ryder]

  News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top Small Cap Stocks To Invest In Right Now: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:

• [By Paul Ausick]

  FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 8% in short interest during the two-week period. Some 7.45 million shares were short as of May 31. The stock’s price was $1.76 at Monday’s market close, a spike of about 1.1% for the day, within a 52-week range of $1.08 to $2.49. Shares traded up about 2.5% in the two-week short interest period, and the number of days to cover rose from 14 to 17.

• [By Logan Wallace]

  FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

• [By Paul Ausick]

  FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 43.9% in short interest during the period. Some 10.68 million shares were short as of June 29. The stock closed most recently at $1.33, down about 1.5% for the day, in a 52-week range of $1.29 to $2.49. Shares traded down more than 20% in the short interest period, and days to cover dropped from six to four.

Top Small Cap Stocks To Invest In Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:

• [By Ethan Ryder]

  State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

• [By Shane Hupp]

  Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

• [By Shane Hupp]

  Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

• [By Max Byerly]

  Compass Capital Management Inc. bought a new position in Canadian National Railway (NYSE:CNI) (TSE:CNR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,535 shares of the transportation company’s stock, valued at approximately $207,000.

• [By Stephan Byrd]

  Brokerages expect Canadian National Railway (NYSE:CNI) (TSE:CNR) to announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.10 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings of $1.00 per share in the same quarter last year, which would indicate a positive year over year growth rate of 3%. The business is scheduled to issue its next quarterly earnings report on Tuesday, July 24th.

Interstellar Holdings Hits Market Cap of $1.74 Million (HOLD)

Interstellar Holdings (CURRENCY:HOLD) traded 5% higher against the dollar during the 24-hour period ending at 18:00 PM E.T. on July 20th. One Interstellar Holdings coin can now be bought for about $0.0025 or 0.00000038 BTC on major exchanges including Cryptopia and Mercatox. Interstellar Holdings has a total market cap of $1.74 million and $6,550.00 worth of Interstellar Holdings was traded on exchanges in the last day. During the last seven days, Interstellar Holdings has traded down 12.7% against the dollar.

Here’s how similar cryptocurrencies have performed during the last day:

Get Interstellar Holdings alerts: MedicCoin (MEDIC) traded down 14.8% against the dollar and now trades at $0.0212 or 0.00000291 BTC. AsiaCoin (AC) traded down 7.9% against the dollar and now trades at $0.0023 or 0.00000032 BTC. Mintcoin (MINT) traded 31.2% lower against the dollar and now trades at $0.0001 or 0.00000002 BTC. GPU Coin (GPU) traded up 18.5% against the dollar and now trades at $0.0352 or 0.00000364 BTC. Renos (RNS) traded 11.1% lower against the dollar and now trades at $0.0174 or 0.00000238 BTC. Digital Rupees (DRS) traded 46.8% higher against the dollar and now trades at $0.0002 or 0.00000003 BTC. AllSafe (ASAFE2) traded 4.2% lower against the dollar and now trades at $0.0110 or 0.00000150 BTC. DigiFinexToken (DFT) traded up 3.7% against the dollar and now trades at $0.69 or 0.00009405 BTC. Bitok (BITOK) traded down 2.2% against the dollar and now trades at $0.0001 or 0.00000001 BTC.

About Interstellar Holdings

HOLD is a proof-of-stake (PoS) coin that uses the Scrypt hashing algorithm. It was first traded on October 31st, 2017. Interstellar Holdings’ total supply is 738,488,498 coins and its circulating supply is 698,772,633 coins. Interstellar Holdings’ official Twitter account is @InterstellarHLD and its Facebook page is accessible here. The official website for Interstellar Holdings is www.interstellarcoin.com.

Interstellar Holdings Coin Trading

Interstellar Holdings can be traded on the following cryptocurrency exchanges: Mercatox and Cryptopia. It is usually not presently possible to purchase alternative cryptocurrencies such as Interstellar Holdings directly using U.S. dollars. Investors seeking to trade Interstellar Holdings should first purchase Bitcoin or Ethereum using an exchange that deals in U.S. dollars such as Changelly, Coinbase or GDAX. Investors can then use their newly-acquired Bitcoin or Ethereum to purchase Interstellar Holdings using one of the exchanges listed above.

Hot Stocks To Watch For 2019

tags:JBSS,MTLS,INT,DE,MSG,

Pepsi (PEP) came onto my radar as it is at or near its 52-week low. I have a theory that many stocks were re-priced our re-valued during the market correction in the winter of 2018. When I saw PEP at these levels I was thinking that this was a broken stock at a good price.

As we can see below, the stock has fallen from ~$120/share in let's say February to $98 in late May. The PE ratio as compressed as well. These are significant moves and the simply explanation of re-valuing companies with tighter multiples may not tell the whole story.

PEP data by YCharts

Hot Stocks To Watch For 2019: John B. Sanfilippo & Son, Inc.(JBSS)

Advisors' Opinion:

• [By Max Byerly]

  The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

• [By Stephan Byrd]

  WINTON GROUP Ltd acquired a new position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 21,466 shares of the company’s stock, valued at approximately $1,242,000. WINTON GROUP Ltd owned about 0.19% of John B. Sanfilippo & Son at the end of the most recent quarter.

• [By Joseph Griffin]

  BidaskClub upgraded shares of John B. Sanfilippo & Son (NASDAQ:JBSS) from a hold rating to a buy rating in a research note released on Wednesday.

• [By Max Byerly]

  John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) shares reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $71.43 and last traded at $70.96, with a volume of 1305 shares trading hands. The stock had previously closed at $69.72.

Hot Stocks To Watch For 2019: Materialise NV(MTLS)

Advisors' Opinion:

• [By Logan Wallace]

  News coverage about Materialise (NASDAQ:MTLS) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Materialise earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the software maker an impact score of 46.5867221134452 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Hot Stocks To Watch For 2019: World Fuel Services Corporation(INT)

Advisors' Opinion:

• [By Lisa Levin]

  World Fuel Services Corporation (NYSE: INT) shares dropped 21 percent to $22.05 following Q1 results.

  Shares of Biglari Holdings Inc. (NYSE: BH) were down 17 percent to $352.05. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

• [By Shane Hupp]

  World Fuel Services (NYSE:INT) has earned an average rating of “Hold” from the seven research firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $38.00.

• [By Stephan Byrd]

  Internet Node Token (CURRENCY:INT) traded 1.6% lower against the US dollar during the 1 day period ending at 21:00 PM ET on June 6th. In the last seven days, Internet Node Token has traded 19.6% lower against the US dollar. Internet Node Token has a total market cap of $32.85 million and $6.97 million worth of Internet Node Token was traded on exchanges in the last 24 hours. One Internet Node Token token can now be bought for $0.22 or 0.00002838 BTC on exchanges including OKEx, CoinEgg and Allcoin.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on World Fuel Services (INT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin]

  World Fuel Services Corporation (NYSE: INT) shares dropped 19 percent to $22.62 following Q1 results.

  Shares of Biglari Holdings Inc. (NYSE: BH) were down 20 percent to $339.00. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

• [By Max Byerly]

  Get a free copy of the Zacks research report on World Fuel Services (INT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Stocks To Watch For 2019: World Energy Solutions Inc(DE)

Advisors' Opinion:

• [By Rich Smith]

  Shares of tractor maker Deere & Company (NYSE:DE) are up 27.5% over the past 12 months, doubling the performance of the S&P 500 already -- and the good news has only just begun, according to one industrials analyst.

• [By Lisa Levin]

  On Friday, the industrial shares rose 0.39 percent. Meanwhile, top gainers in the sector included Deere & Company (NYSE: DE), up 5 percent, and HC2 Holdings, Inc. (NYSE: HCHC) up 4 percent.

• [By Benzinga News Desk]

  Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

  ECONOMIC DATA US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M Existing home sales report for April will be released at 10:00 a.m. ET. The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET. Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET. The Treasury is set to auction 7-year notes at 1:00 p.m. ET. The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET. Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET. Data on money supply for the latest week will be released at 4:30 p.m. ET. ANALYST RATINGS UBS upgrades Deere (NYSE: DE) from Neutral to Buy Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

  This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

• [By Max Byerly]

  Cypress Capital Management LLC WY boosted its position in John Deere (NYSE:DE) by 68.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,350 shares of the industrial products company’s stock after purchasing an additional 550 shares during the period. Cypress Capital Management LLC WY’s holdings in John Deere were worth $210,000 at the end of the most recent quarter.

• [By David Zeiler]

  Finally, investors need to be cautious with multinational stocks. Companies vulnerable to trade war issues include Caterpillar Inc. (NYSE: CAT), 3M Co. (NYSE: MMM), Deere & Co. (NYSE: DE), and Tiffany & Co. (NYSE: TIF).

Hot Stocks To Watch For 2019: Madison Square Garden Inc.(MSG)

Advisors' Opinion:

• [By WWW.GURUFOCUS.COM]

  For the details of Silver Lake Group, L.L.C.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Silver+Lake+Group%2C+L.L.C.

  These are the top 5 holdings of Silver Lake Group, L.L.C.GoDaddy Inc (GDDY) - 15,868,908 shares, 21.3% of the total portfolio. Alibaba Group Holding Ltd (BABA) - 3,587,218 shares, 16.52% of the total portfolio. Sabre Corp (SABR) - 30,019,094 shares, 16.43% of the total portfolio. Broadcom Ltd (AVGO) - 1,618,567 shares, 11.1% of the total portfolio. BlackLine Inc (BL) - 12,543,873 shares, 10.99% of the total portfolio. Share
• [By WWW.GURUFOCUS.COM]

  For the details of Silver Lake Group, L.L.C.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Silver+Lake+Group%2C+L.L.C.

  These are the top 5 holdings of Silver Lake Group, L.L.C.GoDaddy Inc (GDDY) - 11,868,908 shares, 22.42% of the total portfolio. Shares reduced by 25.21%Alibaba Group Holding Ltd (BABA) - 3,587,218 shares, 20.25% of the total portfolio. SMART Global Holdings Inc (SGH) - 11,256,755 shares, 17.26% of the total portfolio. Sabre Corp (SABR) - 22,470,993 shares, 14.83% of the total portfolio. Shares reduced by 25.14%The Madison Square Garden Co (MSG) - 1,233,895 shares, 9.33% of the total portf
• [By Logan Wallace]

  Madison Square Garden Co (NYSE:MSG)’s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $298.43 and last traded at $293.96, with a volume of 26154 shares trading hands. The stock had previously closed at $288.80.

Best Biotech Stocks To Own Right Now

tags:AMGN,ALNY,BIIB,ARQL,

Biotech stocks��Regeneron Pharmaceuticals (REGN),�Biogen (BIIB),�Amgen (AMGN) and Celgene (CELG), among them��have staged nice rallies during the past three months but are still down for 2016. Now, Piper Jaffray’s Joshua Schimmer and team ask: “What’s the trade for the rest of the year?” They answer their own question:

Reuters

Investors are generally lukewarm on biopharma, and many think we’re finally moving towards a ‘stock-pickers’ environment and away from the group trade that has dominated for much of the past year. Some valuations are viewed as more attractive than others, but with few obvious shorts to be found. Much discussion is on M&A target.

Large cap focus: Investors are generally sticking to more liquid names, although we are slowly seeing a return of interest to select small-caps. The general agreement is that fundamentals have changed, biopharma pricing power has eroded, payors/PBMs are wielding considerable power and more uncertainty exists for product outlooks.

Best Biotech Stocks To Own Right Now: Amgen Inc.(AMGN)

Advisors' Opinion:

• [By Cory Renauer]

  The recent surge in biotech investment is terrific for the pace of innovation, but that capital isn't heading toward the industry's bigger older players, a couple of which are looking mighty underappreciated right now. Perhaps the investment community's intense focus on start-ups has created interesting opportunities to snap up shares of these two overlooked biotechs at a very nice price.

  Company (Symbol) Forward P/E Ratio Free Cash Flow, Past 12 Months Cash, Cash Equivalents, and Short-Term Investments as of March 31 AbbVie Inc. (NYSE:ABBV) 12.2 $10.0 billion $9.5 billion Amgen, Inc. (NASDAQ:AMGN) 14.2 $10.9 billion $32.2 billion

  Data source: Yahoo! Finance.

• [By ]

  Booker's report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

• [By Max Byerly]

  Amgen (NASDAQ: AMGN) and aTyr Pharma (NASDAQ:LIFE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

• [By Keith Speights]

  The big reason Humira will maintain its position at the top is the U.S. market. U.S. sales of the drug are projected to be around $12.2 billion in 2024. That's not much lower than Humira's 2017 U.S. sales of nearly $12.4 billion. Will Amgen's (NASDAQ:AMGN) biosimilar Amjevita, which will go on sale in the U.S. effective Jan. 31, 2023, really make that small of a dent in Humira's sales? Not really. The impact will be greater than the 2024 projections indicate.

• [By Trey Thoelcke]

  Amgen Inc. (NASDAQ: AMGN) shares saw a nice bump after the U.S. Food and Drug Administration (FDA) on Thursday approved Aimovig (erenumab), Amgen’s preventive treatment of migraine in adults. It is the first FDA-approved preventive migraine treatment in a new class of drugs, which work by blocking the activity of calcitonin gene-related peptide, which is believed to play a critical role in migraine attacks.

• [By Keith Speights]

  That difficulty hasn't stopped market research firm EvaluatePharma from trying, though. EvaluatePharma recently published a list of the drugmakers with the projected highest value creation from pipeline�products between 2018 and 2024. Here's why Novartis (NYSE:NVS), AbbVie (NYSE:ABBV), Celgene (NASDAQ:CELG), AstraZeneca (NYSE:AZN), and Amgen (NASDAQ:AMGN) ranked at the top.

Best Biotech Stocks To Own Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:

• [By Joseph Griffin]

  BidaskClub lowered shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) from a strong-buy rating to a buy rating in a research report released on Monday.

• [By Sean Williams, Chuck Saletta, and Brian Feroldi]

  So, which biotech stocks should you consider buying in June? That's a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).

• [By Brian Orelli]

  The delay in an FDA decision for Tegsedi puts it behind competitor Alnylam Pharmaceuticals (NASDAQ:ALNY), which expects to hear from the FDA by Aug. 11 for its hATTR drug patisiran. But Sarah Boyce, the president at Akcea Therapeutics, doesn't think a few months will really matter: "We don't really feel that's going to have any impact and the drugs will be close enough together from a launch perspective. So not really [going] to make any adjustments, and we're very well prepared to be ready to launch following approval."

• [By Max Byerly]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.

• [By Logan Wallace]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Although Alnylam has a broad and promising pipeline, we note that most candidates are in mid stages of development. These candidates still have a long way to go before hitting the market. The company relies highly on collaborators for funding. Any development/regulatory setback would be a negative for the company.  However, Alnylam reported positive data from the ATLAS study in the first quarter which led to regulatory filings for its late-stage pipeline candidate patisiran and the FDA set an action date of Aug 11, 2018. The company along with its partners Sanofi and The Medicines Company, restarted fitusiran's ATLAS phase III study and advanced inclisiran in the ORION-9, -10, and -11 phase III studies, respectively, with results expected for both programs in 2019. Alnylam expects to achieve the profile of three marketed products by the end of 2020.”

Best Biotech Stocks To Own Right Now: Biogen Idec Inc(BIIB)

Advisors' Opinion:

• [By Chris Lange]

  Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 3.50 million shares from the previous 3.16 million. The stock recently traded at $262.15, within a 52-week range of $244.28 to $370.57.

• [By Brian Orelli]

  Shares of Ionis Pharmaceuticals (NASDAQ:IONS) ended the day down 10.6% after an earnings report�from partner Biogen (NASDAQ:BIIB) started the day on a sour note. Then shares dropped even further midday after data was released�for IONIS-HTTRx, a treatment for Huntington's disease. Biogen managed to end the day in the green, up 1.1%.

• [By Steve Symington]

  But several individual stocks lagged the broader market. Read on to see why Cerner (NASDAQ:CERN), Biogen (NASDAQ:BIIB), and Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL)�slumped today.

• [By Sean Williams, Chuck Saletta, and Brian Feroldi]

  As noted, the ability to take numerous swings for the fence makes Ionis special. It's often a marvel when a mid-cap drugmaker has a half-dozen experimental drugs, let alone one working with 25. Spinal muscular atrophy drug Spinraza, which was licensed to Biogen (NASDAQ:BIIB), is one such drug that's put Ionis and its antisense technology on the map. Last year, Spinraza netted "just" $882 million in total sales, but delivered $364 million globally in the first quarter of 2018. That extrapolates out to more than $1.4 billion, which means added royalty revenue for Ionis.

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close was Biogen Inc. (NASDAQ: BIIB) which traded down over 5% at $288.75. The stock��s 52-week range is $249.17 to $370.57. Volume was 3.2 million compared to the daily average volume of 1.7 million.

• [By Jim Crumly]

  As for individual stocks, Biogen (NASDAQ:BIIB) made headlines with positive results from a trial of an Alzheimer's drug, and PriceSmart (NASDAQ:PSMT) fell after reporting earnings.

Best Biotech Stocks To Own Right Now: ArQule Inc.(ARQL)

Advisors' Opinion:

• [By Logan Wallace]

  ValuEngine downgraded shares of ArQule (NASDAQ:ARQL) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday.

  Several other brokerages also recently issued reports on ARQL. Zacks Investment Research upgraded shares of ArQule from a hold rating to a buy rating and set a $2.75 target price for the company in a research note on Tuesday, May 8th. B. Riley set a $4.00 target price on shares of ArQule and gave the company a buy rating in a research note on Monday, March 26th. Roth Capital raised their target price on shares of ArQule from $5.00 to $6.00 and gave the company a buy rating in a research note on Tuesday, April 17th. BidaskClub upgraded shares of ArQule from a hold rating to a buy rating in a research note on Saturday, May 19th. Finally, Leerink Swann upgraded shares of ArQule from a market perform rating to an outperform rating in a research note on Thursday, April 5th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Buy and a consensus price target of $5.35.

• [By Money Morning Staff Reports]

  But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

  Penny Stock Current Share Price Law Month's Gain �Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

  While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

• [By Lisa Levin] Gainers Foot Locker, Inc. (NYSE: FL) rose 15.3 percent to $53.50 in pre-market trading after the company reported better-than-expected results for its first quarter. Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 10.4 percent to $4.58 in pre-market trading. Evofem Biosciences reported closing of public offering of common stock and warrants. Resonant Inc. (NASDAQ: RESN) rose 7.3 percent to $4.88 in pre-market trading after declining 1.94 percent on Thursday. SolarEdge Technologies, Inc. (NASDAQ: SEDG) shares rose 5.7 percent to $59.65 in pre-market trading after falling 8.43 percent on Thursday. Yirendai Ltd. (NYSE: YRD) rose 5 percent to $30.00 in pre-market trading after reporting Q1 results. Deckers Outdoor Corp (NYSE: DECK) rose 4.9 percent to $108.75 in pre-market trading after reporteingd better-than-expected results for its fiscal fourth quarter. Blue Apron Holdings, Inc. (NYSE: APRN) rose 4.2 percent to $3.21 in pre-market trading after gaining 3.70 percent on Thursday. Recro Pharma, Inc. (NASDAQ: REPH) rose 4 percent to $5.85 in pre-market trading after dropping 54.67 percent on Thursday. ArQule, Inc. (NASDAQ: ARQL) rose 3.8 percent to $4.70 in pre-market trading after gaining 4.86 percent on Thursday. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares rose 2.9 percent to $2.85 in pre-market trading after climbing 7.78 percent on Thursday. Bilibili Inc. (NASDAQ: BILI) shares rose 2.5 percent to $14.20 in pre-market trading after surging 11.33 percent on Thursday.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Logan Wallace]

  BidaskClub upgraded shares of ArQule (NASDAQ:ARQL) from a hold rating to a buy rating in a report released on Saturday.

  A number of other research firms have also issued reports on ARQL. Roth Capital upped their price target on ArQule from $5.00 to $6.00 and gave the company a buy rating in a research report on Tuesday, April 17th. Leerink Swann upgraded ArQule from a market perform rating to an outperform rating in a research report on Thursday, April 5th. Zacks Investment Research lowered ArQule from a buy rating to a hold rating in a research report on Wednesday, April 4th. ValuEngine upgraded ArQule from a hold rating to a buy rating in a research report on Wednesday, May 2nd. Finally, B. Riley set a $4.00 price target on ArQule and gave the company a buy rating in a research report on Monday, March 26th. Seven analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and an average target price of $4.69.

FY2018 EPS Estimates for BHP Billiton Limited Increased by Jefferies Financial Group (BHP)

BHP Billiton Limited (NYSE:BHP) – Equities researchers at Jefferies Financial Group increased their FY2018 earnings estimates for BHP Billiton in a research note issued to investors on Monday, July 9th. Jefferies Financial Group analyst C. Lafemina now expects that the mining company will earn $3.16 per share for the year, up from their previous estimate of $3.12.

Get BHP Billiton alerts:

A number of other brokerages have also recently weighed in on BHP. Bank of America cut BHP Billiton from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 5th. Deutsche Bank upgraded BHP Billiton from a “hold” rating to a “buy” rating in a research note on Tuesday, April 10th. Investec cut BHP Billiton from a “buy” rating to a “hold” rating in a research note on Friday, June 15th. Barclays upgraded BHP Billiton from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 4th. Finally, Royal Bank of Canada upgraded BHP Billiton from an “underperform” rating to a “sector perform” rating in a research note on Tuesday, April 3rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $45.67.

Shares of BHP Billiton opened at $49.65 on Wednesday, according to MarketBeat.com. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.75 and a quick ratio of 1.40. The firm has a market cap of $82.17 billion, a P/E ratio of 19.36, a P/E/G ratio of 3.05 and a beta of 1.20. BHP Billiton has a 1-year low of $38.26 and a 1-year high of $52.17.

Large investors have recently made changes to their positions in the stock. Private Capital Group LLC increased its position in BHP Billiton by 1,157.5% during the 1st quarter. Private Capital Group LLC now owns 2,515 shares of the mining company’s stock valued at $112,000 after buying an additional 2,315 shares in the last quarter. Smart Portfolios LLC acquired a new position in BHP Billiton during the 1st quarter valued at about $121,000. Summit Trail Advisors LLC increased its position in BHP Billiton by 4,776.7% during the 1st quarter. Summit Trail Advisors LLC now owns 161,905 shares of the mining company’s stock valued at $162,000 after buying an additional 158,585 shares in the last quarter. Sensato Investors LLC acquired a new position in BHP Billiton during the 4th quarter valued at about $222,000. Finally, Roundview Capital LLC acquired a new position in BHP Billiton during the 1st quarter valued at about $240,000. 3.32% of the stock is currently owned by institutional investors.

BHP Billiton Company Profile

BHP Billiton Limited is a global resources company. The Company is a producer of various commodities, including iron ore, metallurgical coal, copper and uranium. Its segments include Petroleum, Copper, Iron Ore and Coal. The Petroleum segment is engaged in the exploration, development and production of oil and gas.

An under-the-radar defensive stock is surging as safety plays make a comeback

As trade war chaos envelops asset classes from stocks to commodities to currencies, defensive corners of the market like consumer staples and utilities have fallen back into favor. Within consumer staples, one name that may fly under the radar for some investors has acted particularly well, catching my eye in recent sessions.

While the staples-tracking XLP ETF has seen a notable gain just in the last month and a half, food and commodities processing company Archer Daniels Midland, one of the XLP��s components, has been climbing upward all year.

Archer Daniels Midland year to date

In fact, the stock has jumped more than 15 percent year to date, and on Wednesday fell modestly to snap its longest daily losing streak of the year.

Where it’s been

In March, shares of Archer Daniels Midland saw an upside breakout of a technical symmetrical triangle pattern, and now stand 23 percent above their November 2017 lows. That��s in contrast to the S&P 500��s rally of 8.8 percent in the same time period.

Now, the stock is bumping up against yet another key resistance level, going back to its 2016 highs. If it can breach those levels to the upside in any meaningful way (it��s already broken slightly above that level), that��s going to mark a significant ��higher high.��

That would be very bullish for this defensive stock.

Where it’s going

It��s important to remember, however, that the stock is quite overbought on a near-term basis, as reflected in its relative strength index. Therefore, those 2016 highs may prove to be some kind of short-term resistance that could compel the stock to take a near-term ��breather.�� In other words, shares of Archer Daniels Midland may have to see a pullback to work off their overbought condition.

Vote Vote to see results Total Votes:

Not a Scientific Survey. Results may not total 100% due to rounding.

Disclaimer

Entegra Financial (ENFC) Earning Somewhat Favorable Press Coverage, Report Shows

Media coverage about Entegra Financial (NASDAQ:ENFC) has been trending somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Entegra Financial earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the bank an impact score of 44.2162695807625 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

NASDAQ ENFC traded up $0.05 on Wednesday, hitting $30.25. The stock had a trading volume of 19,100 shares, compared to its average volume of 12,469. Entegra Financial has a one year low of $22.00 and a one year high of $30.70. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 1.57. The stock has a market cap of $208.03 million, a price-to-earnings ratio of 21.30 and a beta of 0.25.

Get Entegra Financial alerts:

Entegra Financial (NASDAQ:ENFC) last posted its earnings results on Thursday, April 19th. The bank reported $0.51 EPS for the quarter, missing the consensus estimate of $0.54 by ($0.03). Entegra Financial had a return on equity of 7.90% and a net margin of 8.03%. The firm had revenue of $14.05 million during the quarter, compared to the consensus estimate of $14.52 million. equities research analysts expect that Entegra Financial will post 2.1 earnings per share for the current fiscal year.

Several research firms have commented on ENFC. Compass Point upgraded shares of Entegra Financial from a “neutral” rating to a “buy” rating and set a $27.00 target price for the company in a research report on Thursday, June 28th. ValuEngine cut shares of Entegra Financial from a “buy” rating to a “hold” rating in a research report on Thursday, May 3rd. Sandler O’Neill set a $33.00 target price on shares of Entegra Financial and gave the stock a “buy” rating in a research report on Monday, April 23rd. Finally, Zacks Investment Research cut shares of Entegra Financial from a “buy” rating to a “hold” rating in a research report on Monday, March 26th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $31.25.

Entegra Financial Company Profile

Entegra Financial Corp. operates as the bank holding company for Entegra Bank that provides various retail and commercial banking products and services in the United States. The company offers deposit accounts, including savings accounts, commercial and regular checking accounts, money market accounts, and individual retirement accounts, as well as certificates of deposit.

Earnings: 2 Hot Growth Stocks to Watch Next Week

As earnings season begins to kick into gear, next week features stocks of all shapes and sizes. But two stocks I'll be watching are growth stocks Netflix�(NASDAQ:NFLX) and Intuitive Surgical (NASDAQ:ISRG). Both companies are benefiting from double-digit growth in revenue and earnings per share. When these companies report their second-quarter results next week, investors will be watching to see if they can keep executing well on the growth opportunities before them.

Ahead of their results next week, here's a look at both companies as well as a preview of one key area to watch for each.

Image source: Getty Images.

Netflix

The streaming TV company is undoubtedly the hotter stock of these two. Not only is this evident by its 176% gain in the past 12 months and its 43% rise in the past three, but also by the company's frothy price-to-sales ratio of 5.9�-- nearly double the average price-to-sales ratio of stocks in the media industry.�Of course, Netflix has certainly earned its higher valuation. Highlighting the company's steep growth recently, Netflix's first-quarter revenue and EPS increased 13% and 56%, respectively.

An important area�for investors to watch when Netflix reports its second-quarter results next week is international memberships. Thanks to strong growth in international subscribers on the heels of the company's massive global expansion in 2015, Netflix's international segment represented half of its revenue and 55% of overall memberships in Q1.�

Management expects to add 6.2 million members in its second quarter, up from the 4.95 million in the year-ago quarter. Of these 6.2 million new members, Netflix forecasts 5 million to come from its international segment.

Netflix reports its second-quarter results on July 16 after market close.�

Intuitive Surgical

The maker of the minimally invasive surgical robot named da Vinci�has seen accelerated momentum recently. First-quarter revenue and EPS rose 25% and 55%, respectively. Intuitive Surgical's stock price has risen rapidly, too. Shares are up 60% in the past 12 months, giving the stock a premium price-to-sales valuation of 18 -- far above the average of five for stocks in the medical instruments and supplies industry.�

A key metric to watch when Intuitive Surgical reports second-quarter results will be its growth in da Vinci�procedures. Growth in procedures using da Vinci systems offers a good indicator of customers'�willingness to adopt and utilize Intuitive Surgical's products and services. The company has been on a roll with this metric, as procedures increased 15% year over year in the first quarter of 2018.�In the company's fourth-quarter 2017 conference call, management had forecast procedure growth in 2018 to increase in a range of 11% to 15%. But with first-quarter procedure growth coming in at the high end of management's range, Intuitive Surgical now expects procedure growth of 12% to 15% during the year, management said during its�first-quarter earnings call.

Investors should look for similar growth in da Vinci procedures in the second quarter of 2018.

Intuitive Surgical is scheduled to report its second-quarter results after market close on July 19.

So, mark your calendar for Monday and Thursday to watch the second-quarter earnings reports for Netflix and Intuitive Surgical.�

LifePoint Health (LPNT) Receiving Positive Media Coverage, Analysis Shows

Headlines about LifePoint Health (NASDAQ:LPNT) have trended positive this week, Accern reports. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a news impact score of 0.44 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.0016583450414 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

LifePoint Health traded up $0.30, hitting $48.75, during trading on Tuesday, MarketBeat reports. 504 shares of the company’s stock traded hands, compared to its average volume of 690,271. The firm has a market cap of $1.87 billion, a price-to-earnings ratio of 13.46, a PEG ratio of 1.24 and a beta of 0.52. The company has a quick ratio of 1.55, a current ratio of 1.76 and a debt-to-equity ratio of 1.28. LifePoint Health has a 1 year low of $41.45 and a 1 year high of $66.05.

Get LifePoint Health alerts:

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, May 4th. The company reported $1.22 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.09. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. LifePoint Health’s revenue was down 1.7% compared to the same quarter last year. During the same period last year, the firm earned $1.07 earnings per share. analysts anticipate that LifePoint Health will post 4.3 EPS for the current fiscal year.

A number of equities analysts have recently commented on LPNT shares. Robert W. Baird reaffirmed a “buy” rating and set a $54.00 target price on shares of LifePoint Health in a research report on Tuesday, March 27th. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research report on Wednesday, July 4th. BidaskClub lowered shares of LifePoint Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 26th. Mizuho reissued a “hold” rating and set a $51.00 price objective on shares of LifePoint Health in a report on Thursday, March 22nd. Finally, SunTrust Banks reissued a “hold” rating and set a $58.00 price objective on shares of LifePoint Health in a report on Monday, May 7th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $53.67.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Allied Motion Technologies (AMOT) Reaches New 12-Month High at $50.26

Allied Motion Technologies, Inc. (NASDAQ:AMOT) shares reached a new 52-week high during trading on Thursday . The stock traded as high as $50.26 and last traded at $50.29, with a volume of 3496 shares traded. The stock had previously closed at $48.18.

AMOT has been the subject of several research analyst reports. BidaskClub lowered Allied Motion Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 19th. ValuEngine upgraded Allied Motion Technologies from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. TheStreet upgraded Allied Motion Technologies from a “c+” rating to a “b+” rating in a research report on Wednesday, May 30th. Finally, Zacks Investment Research upgraded Allied Motion Technologies from a “hold” rating to a “buy” rating and set a $53.00 price target for the company in a research report on Thursday, May 24th.

Get Allied Motion Technologies alerts:

The stock has a market capitalization of $459.86 million, a P/E ratio of 40.72, a price-to-earnings-growth ratio of 4.05 and a beta of 1.89. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.57 and a quick ratio of 1.55.

Allied Motion Technologies (NASDAQ:AMOT) last released its quarterly earnings results on Wednesday, May 2nd. The technology company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.30 by $0.15. Allied Motion Technologies had a return on equity of 14.64% and a net margin of 3.58%. The business had revenue of $76.58 million during the quarter. analysts forecast that Allied Motion Technologies, Inc. will post 1.71 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMOT. Millennium Management LLC boosted its holdings in Allied Motion Technologies by 1,044.1% in the fourth quarter. Millennium Management LLC now owns 103,208 shares of the technology company’s stock valued at $3,415,000 after purchasing an additional 94,187 shares during the period. Ancora Advisors LLC purchased a new position in Allied Motion Technologies in the first quarter valued at $2,687,000. Renaissance Technologies LLC boosted its holdings in Allied Motion Technologies by 53.3% in the fourth quarter. Renaissance Technologies LLC now owns 185,800 shares of the technology company’s stock valued at $6,148,000 after purchasing an additional 64,600 shares during the period. Mackay Shields LLC purchased a new position in Allied Motion Technologies in the first quarter valued at $1,690,000. Finally, EAM Global Investors LLC purchased a new position in Allied Motion Technologies in the first quarter valued at $1,238,000. Institutional investors and hedge funds own 49.34% of the company’s stock.

About Allied Motion Technologies

Allied Motion Technologies, Inc designs, manufactures, and sells precision and specialty motion control components and systems that are used in a range of industries worldwide. It provides automotive brushless (BL) DC motors, power steering solutions, and special purpose motors; fractional horsepower permanent magnet DC and BLDC motors serving a range of original equipment applications; and high performance BLDC motors, including servo motors, frameless motors, torque motors, slot less motors, high resolution encoders, and motor/encoder assemblies.

Even in the gig economy, women earn less than men

There have been a lot of headlines about the gender wage gap among full-time wage and salary workers. Researchers have found that pay disparities persist due to a combination of women working in lower-paid occupations, taking time off to have kids and discrimination.

But what about the world of online platforms, like Lyft and Instacart, where wages are often set equally for a given task and the customer doesn't see the gender of the worker before the job is booked?

Turns out there's a gender wage gap there, too.

A study released last week by economists from Stanford University and the University of Chicago using data from more than a million Uber drivers uncovered a 7% hourly earnings gap between men and women on the ride-sharing platform.

When looking deeper into the data, the researchers found that nearly half of that gap was due to male workers simply driving faster. Male workers are also more likely to have stuck with the app for a longer period of time, allowing them to accumulate skills that boost their productivity. And they also tend to drive in areas that can be more lucrative, including those with high crime rates and more liquor stores, which female drivers avoid.

"Our results suggest that there is no reason to expect the 'gig' economy to close gender differences," the authors wrote.

Their findings aren't unique among studies of non-traditional work. According to the Bureau of Labor Statistics' recently released Contingent Worker Survey, men in temporary jobs make about 15% more than women per week, and male independent contractors make 21.5% more per week than female independent contractors.

A 2016 study using a different data source, a longitudinal survey of hundreds of individuals also maintained by the BLS, found a significant earnings differential between self-employed men and women. Earlier this year, the accounting service Freshbooks found the gap was 28%, and survey results showed that many women reported gender discrimination and felt they had to charge less than men in order to win clients.

Shelly Steward, who studies the gig economy at the Aspen Institute, says that the independent contractor gap may be due to women taking on lower-wage contract work as supplemental income �� such as babysitting or home-based sales jobs �� rather than more lucrative primary income, like being an insurance agent or a plumber.

But even when men and women do exactly the same type of work, such as driving for Uber, factors like where they live and their relative appetites for risk can open up a gap.

"We live in a gendered and unequal society, and that impacts independent work just like it impacts traditional work," Steward says.

The Uber study offered one reason for optimism: Much of the gender-based wage disparity stemmed from a difference in experience, suggesting that women could pull even with men by sticking with the app longer and picking up more skills.

"Overall, our results suggest that on-the-job learning may contribute to the gender earnings gap more broadly in the economy than previously thought," the authors write.

Crude Oil Price Drops on Unexpected Stockpile Build

The U.S. Energy Information Administration (EIA) released its weekly petroleum status report Thursday morning showing that U.S. commercial crude inventories increased by 1.2 million barrels last week, maintaining a total U.S. commercial crude inventory of 417.9 million barrels. The commercial crude inventory is about 2% below the five-year average for this time of year.

Tuesday evening the American Petroleum Institute (API) reported that crude inventories fell by 4.5 million barrels in the week ending June 29. Gasoline inventories decreased by 3.1 million barrels and distillate stockpiles fell by about 440,000 barrels. For the same period, analysts expected crude inventories to decrease by about 4.5 million barrels. Gasoline inventories were seen down by 2.5 million barrels and distillate inventories were expected to fall by 1 250,000 barrels.

Total gasoline inventories decreased by 1.5 million barrels last week, according to the EIA, and remained about 6% above the five-year average range. U.S. refineries produced about 10.3 million barrels of gasoline a day last week, up by about 200,000 barrels a day compared to the prior week. Total motor gasoline supplied (the agency’s proxy for demand) averaged 9.7 million barrels a day for the past four weeks, also up about 200,000 barrels a day compared with the prior week.

Before the EIA report, benchmark West Texas Intermediate (WTI) crude for August delivery traded down about 0.8%, at around $74.01 a barrel, and fell to around $73.25 (down about 1.8%) shortly after the report’s release. WTI settled at $74.14 on Tuesday and opened at $73.63 Thursday morning. The 52-week range on August futures is $46.51 to $75.57.

U.S. President Trump continues to bash Saudi Arabia, in particular, and OPEC, in general, to raise production, which he believes will lead to lower prices. Trump points to the 2 million barrels that the Saudis claim as spare capacity as the oil that should be pumped right now.

What Trump fails to understand (or care about if he does understand) is that the Saudi spare capacity has reached an all-time low and that, even if they wanted to add 2 million barrels a day to global production by the end of the week, it couldn’t be done. Nor is it in their best interests to open the taps further. The president will just have to wait or put a little more effort into crushing Iran, something both he and the Saudis agree needs to happen.

U.S. crude oil exports fell by 664,000 barrels a day last week and U.S. production remained flat again at 10.9 million barrels. Exports averaged 2.34 million barrels a day last week and have a cumulative daily average for the year of 1.83 million barrels a day, a 142% increase over the year-ago export total.

Distillate inventories rose by 100,000 barrels last week and are about 13% below the five-year average range for this time of year. Distillate product supplied averaged 4 million barrels a day for the past four weeks, up by about 200,000 compared with the prior week. Distillate production averaged 5.5 million barrels a day last week, up by about 100,000 compared to the prior week’s production.

For the past week, crude imports averaged 9.1 million barrels a day, up by 699,000 compared with the previous week. Refineries were running at 97.1% of capacity, with daily input averaging 17.7 million barrels a day, about 163,000 less than the previous week’s average. Exports of refined products fell by 404,000 barrels a day last week to 5.14 million.

According to AAA, the current national average pump price per gallon of regular gasoline is $2.866, up nearly two cents from $2.848 a week ago and down more than seven cents per gallon compared with the month-ago price. Last year at this time, a gallon of regular gasoline cost $2.231 on average in the United States.

Here is a look at how share prices for two blue-chip stocks and two exchange-traded funds reacted to this latest report.

Exxon Mobil Corp. (NYSE: XOM) traded up about 0.4%, at $82.58 in a 52-week range of $72.16 to $89.30. Over the past 12 months, Exxon stock has traded up about 2.4%.

Chevron Corp. (NYSE: CVX) traded up about 0.2%, at $124.97 in a 52-week range of $102.55 to $133.88. As of last night’s close, Chevron shares are trading up about 19.4% over the past year.

The United States Oil ETF (NYSEARCA: USO) traded down about 0.3%, at $14.88 in a 52-week range of $9.00 to $15.08.

The VanEck Vectors Oil Services ETF (NYSEAMERICAN: OIH) traded up about 0.3%, at $25.84 in a 52-week range of $21.70 to $29.87.

ALSO READ: Merrill Lynch Issues Top 8 US Stock Ideas for Q3 2018

Best Gold Stocks To Buy For 2019

tags:GGB,AFAM,PKX, LISTEN TO ARTICLE 2:18 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Russia is rethinking what counts as a haven asset as it duels with the U.S.

Although investors usually seek safety in U.S. debt, Russia cut its holdings of Treasuries nearly in half in April as Washington slapped the harshest sanctions to date on a selection of Russian companies and individuals. In a shift Danske Bank A/S attributed to a deepening “geopolitical standoff,” Russia is instead keeping up its purchases of gold.

Best Gold Stocks To Buy For 2019: Gerdau S.A.(GGB)

Advisors' Opinion:

• [By Matthew DiLallo]

  Shares of Gerdau (NYSE:GGB) tumbled more than 10% by 2:45 p.m. EDT Thursday in what was a tumultuous day for stocks in Brazil. The Brazil-based steel company sold off along with that country's stock market amid fears that the recent trucker strike could have a deep impact on the economy.

• [By Logan Wallace]

  Gerdau (NYSE:GGB) has been assigned an average recommendation of “Buy” from the eleven analysts that are currently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $4.00.

• [By Shane Hupp]

  AMG Funds LLC lessened its stake in Gerdau (NYSE:GGB) by 12.1% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 256,979 shares of the basic materials company’s stock after selling 35,501 shares during the quarter. AMG Funds LLC’s holdings in Gerdau were worth $1,198,000 at the end of the most recent reporting period.

• [By Max Byerly]

  Gerdau (NYSE:GGB) fell 7.6% on Tuesday . The stock traded as low as $3.99 and last traded at $4.00. 20,132,700 shares were traded during mid-day trading, an increase of 80% from the average session volume of 11,155,967 shares. The stock had previously closed at $4.33.

Best Gold Stocks To Buy For 2019: Almost Family Inc(AFAM)

Advisors' Opinion:

• [By Max Byerly]

  Schwab Charles Investment Management Inc. boosted its position in shares of Almost Family Inc (NASDAQ:AFAM) by 12.6% during the first quarter, HoldingsChannel reports. The firm owned 62,175 shares of the company’s stock after buying an additional 6,953 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Almost Family were worth $3,482,000 at the end of the most recent reporting period.

Best Gold Stocks To Buy For 2019: POSCO(PKX)

Advisors' Opinion:

• [By Max Byerly]

  Media coverage about POSCO (NYSE:PKX) has trended somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. POSCO earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave news headlines about the basic materials company an impact score of 46.5366586800129 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

• [By Ethan Ryder]

  Mount Yale Investment Advisors LLC acquired a new position in POSCO (NYSE:PKX) during the first quarter, according to its most recent filing with the SEC. The firm acquired 2,035 shares of the basic materials company’s stock, valued at approximately $160,000.